LIFECORE BIOMEDICAL, INC. Increase (Decrease) in Due from Related Parties
LIFECORE BIOMEDICAL, INC. (LFCR) reported Increase (Decrease) in Due from Related Parties of $2.00 thousand for the 12-month period ending 2015-05-31, per its 10-K filed 2015-07-31.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDueFromRelatedParties · last filed 2015-07-31
- LIFECORE BIOMEDICAL, INC. increase (decrease) in due from related parties for the quarter ending 2015-05-31 was $271.00K, a 42.34% decline year-over-year.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in due from related parties for the quarter ending 2015-03-01 was -$127.00K, a 318.97% decline year-over-year.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in due from related parties for the quarter ending 2014-11-30 was -$176.00K.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in due from related parties for the quarter ending 2014-08-31 was $34.00K.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in due from related parties for fiscal 2015 was $2.00K.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in due from related parties for fiscal 2014 was -$12.00K, a 103.45% decline from fiscal 2013.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in due from related parties for fiscal 2013 was $348.00K.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in due from related parties for fiscal 2012 was -$130.00K.
| Period end | Increase (Decrease) in Due from Related Parties 3 month | Increase (Decrease) in Due from Related Parties 3 month as first filed | Increase (Decrease) in Due from Related Parties 6 month | Increase (Decrease) in Due from Related Parties 6 month as first filed | Increase (Decrease) in Due from Related Parties 9 month | Increase (Decrease) in Due from Related Parties 9 month as first filed | Increase (Decrease) in Due from Related Parties 12 month | Increase (Decrease) in Due from Related Parties 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2015-05-31 | $271.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-31 | $144.00K derived: sum of 2 quarters · filed 2015-07-31 | -$32.00K derived: sum of 3 quarters · filed 2015-07-31 | $2.00K 10-K · filed 2015-07-31 | ||||
| 2015-03-01 | -$127.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-04-02 | -$303.00K derived: sum of 2 quarters · filed 2015-04-02 | -$269.00K 10-Q · filed 2015-04-02 | $201.00K derived: sum of 4 quarters · filed 2015-07-31 | ||||
| 2014-11-30 | -$176.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-01-09 | -$142.00K 10-Q · filed 2015-01-09 | $328.00K derived: sum of 3 quarters · filed 2015-07-31 | $386.00K derived: sum of 4 quarters · filed 2015-07-31 | ||||
| 2014-08-31 | $34.00K 10-Q · filed 2014-10-08 | $504.00K derived: sum of 2 quarters · filed 2015-07-31 | $562.00K derived: sum of 3 quarters · filed 2015-07-31 | $488.00K derived: sum of 4 quarters · filed 2015-07-31 | ||||
| 2014-05-25 | $470.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-31 | $528.00K derived: sum of 2 quarters · filed 2015-07-31 | $454.00K derived: sum of 3 quarters · filed 2015-07-31 | -$12.00K 10-K · filed 2015-07-31 | ||||
| 2014-02-23 | $58.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-04-02 | -$16.00K derived: sum of 2 quarters · filed 2015-04-02 | -$482.00K 10-Q · filed 2015-04-02 | -$123.00K derived: sum of 4 quarters · filed 2015-07-31 | ||||
| 2013-11-24 | -$74.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-01-09 | -$540.00K 10-Q · filed 2015-01-09 | -$181.00K derived: sum of 3 quarters · filed 2015-07-31 | -$182.00K derived: sum of 4 quarters · filed 2015-07-31 | ||||
| 2013-08-25 | -$466.00K 10-Q · filed 2014-10-08 | -$107.00K derived: sum of 2 quarters · filed 2015-07-31 | -$108.00K derived: sum of 3 quarters · filed 2015-07-31 | -$63.00K derived: sum of 4 quarters · filed 2015-07-31 | ||||
| 2013-05-26 | $359.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-31 | $358.00K derived: sum of 2 quarters · filed 2015-07-31 | $403.00K derived: sum of 3 quarters · filed 2015-07-31 | $348.00K 10-K · filed 2015-07-31 | ||||
| 2013-02-24 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-03-28 | $44.00K derived: sum of 2 quarters · filed 2014-03-28 | -$11.00K 10-Q · filed 2014-03-28 | -$66.00K derived: sum of 4 quarters · filed 2014-08-01 | ||||
| 2012-11-25 | $45.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-01-03 | -$10.00K 10-Q · filed 2014-01-03 | -$65.00K derived: sum of 3 quarters · filed 2014-08-01 | -$1.00K derived: sum of 4 quarters · filed 2014-08-01 | ||||
| 2012-08-26 | -$55.00K 10-Q · filed 2013-09-26 | $55.00K 10-Q · filed 2012-10-03 | -$110.00K derived: sum of 2 quarters · filed 2014-08-01 | -$46.00K derived: sum of 3 quarters · filed 2014-08-01 | -$145.00K derived: sum of 4 quarters · filed 2014-08-01 | |||
| 2012-05-27 | -$55.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-01 | $9.00K derived: sum of 2 quarters · filed 2014-08-01 | -$90.00K derived: sum of 3 quarters · filed 2014-08-01 | -$130.00K 10-K · filed 2014-08-01 | $130.00K 10-K · filed 2012-08-08 | |||
| 2012-02-26 | $64.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-04-04 | -$35.00K derived: sum of 2 quarters · filed 2013-04-04 | -$75.00K 10-Q · filed 2013-04-04 | $75.00K 10-Q · filed 2012-03-28 | -$907.00K derived: sum of 4 quarters · filed 2013-08-07 | |||
| 2011-11-27 | -$99.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2013-01-04 | -$139.00K 10-Q · filed 2013-01-04 | $139.00K 10-Q · filed 2012-01-05 | -$971.00K derived: sum of 3 quarters · filed 2013-08-07 | ||||
| 2011-08-28 | -$40.00K 10-Q/A · filed 2013-01-02 | $40.00K 10-Q · filed 2011-10-05 | -$872.00K derived: sum of 2 quarters · filed 2013-08-07 | |||||
| 2011-05-29 | -$832.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-07 | -$276.00K 10-K · filed 2013-08-07 | $276.00K 10-K · filed 2012-08-08 | |||||
| 2011-02-27 | $556.00K 10-Q · filed 2012-03-28 | |||||||
| 2010-11-28 | $268.00K 10-Q · filed 2012-01-05 | |||||||
| 2010-08-29 | $95.00K 10-Q · filed 2011-10-05 | |||||||
| 2010-05-30 | -$97.00K 10-K · filed 2012-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |